Global Market Forecasts 2024-2029 Including Strategic Analysis of Meril Life, Anthony Products, Medtronic, Entsho, and Innovia Medical, and More

The market for nasal tamponade devices

Dublin, July 9, 2024 (GLOBE NEWSWIRE) — The report “Nasal Tampons Market – Forecast 2024-2029” has been added to Research & Marketing.com offering.

The global nasal tampon market is expected to grow at a CAGR of 4.97% from USD 178.456 million in 2022 to USD 250.677 million in 2029.

The increasing prevalence of nasal problems coupled with the rise in awareness and increased number of surgeries are the major factors driving the growth of the nasal tamponade device market. Moreover, the rapidly growing elderly population along with technological advancements in packaging are further considered to accelerate the market expansion.

Growing incidence of nasal diseases

As the incidence of nasal conditions such as chronic sinusitis, deviated nasal septum, and nasal trauma increases, there is a growing need for nasal packing to treat these conditions following surgery or as part of a treatment plan.

For example, sinusitis affects about 30 million people in the United States alone each year. It has an economic impact of billions of dollars and millions of days of missed work, according to the Sinus & Allergy Wellness Center. In addition, sinusitis is responsible for about 73 million days of restricted activity each year. About 70 to 80 percent of people have a noticeable deviation of the nasal septum, according to the Mayo Clinic.

Growing number of surgical procedures

The number of nose surgeries, including rhinoplasty, septoplasty, and sinus surgery, is increasing worldwide. These procedures often require the use of nasal packing to control bleeding, promote healing, and ensure optimal surgical results.

For example, the Department of Otolaryngology at Michigan Health University performs nearly 500 nasal surgeries and has about 16 million patient visits per year. In addition, about 700 functional endoscopic sinus procedures are performed at UT Southwestern each year, according to M.D., professor of otolaryngology.

Advances in packaging technology

Technological innovations have led to the development of more effective and patient-friendly nasal packing devices. These advances include the use of biocompatible materials, improved designs, and less invasive insertion techniques.

The use of biocompatible materials such as medical silicone, hydrogels and absorbable polymers in nasal packing minimizes tissue irritation, reduces the risk of allergic reactions and promotes better healing. Advances in 3D printing technology allow for the creation of personalized nasal packings adapted to the nasal anatomy of individual patients. This promotes better fit and better postoperative results.

Additionally, some nasal tamponades contain substances that release medications or therapeutic agents directly into the nasal cavity, which speeds healing, reduces inflammation and prevents infection.

The story continues

Aging society

The aging population is more prone to nasal and sinus problems. As the world’s population ages, the demand for nasal surgeries and related devices is likely to increase, which will boost the nasal tampon market. People suffering from geriatric rhinitis may experience symptoms such as blocked or congested nasal passages, excessive nasal discharge, itchy nose, sneezing, and dryness or crusting of the nasal passages.

For example, according to the WHO, the percentage of people over the age of 60 worldwide will increase from 12% to 22% between 2015 and 2050.

Raising awareness and education

As patients and healthcare professionals become more aware of the benefits of proper postoperative care, the nasal packing market is likely to grow. Several initiatives are being undertaken to achieve this.

For example, in March 2021, Henry Ford, MD, launched a global research project to increase interdisciplinary collaboration between otolaryngologists and dentists worldwide in the detection of sinusitis (OSD). Additionally, the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) annually supports the recognition of World Sinus Health Awareness Day.

In 2022, sponsorship was in collaboration with the American Rhinologic Society and corporate partner Medtronic.

The nasal tampon market has experienced growth and development, but certain constraints or challenges may affect its expansion. For example, the development and production of advanced nasal tampons using state-of-the-art materials and technologies may lead to higher production costs.

These costs can then impact pricing and availability for patients and healthcare providers. Disposable nasal tampons can contribute to medical waste. As sustainability becomes an increasingly important issue, there may be pressure to develop environmentally friendly packaging solutions.

North America is expected to grow significantly

North America is expected to hold a significant share in the nasal tamponade market during the forecast period.

Factors attributed to such a share include the growing use of nasal packing to treat the growing number of patients with nosebleeds due to the growing number of nasal and sinus disorders, as well as the growth of the number of market players in the region. For example, chronic sinusitis affects almost 31 million people in the U.S., according to University of Michigan Health.

Major market players

• Anthony Products is a company specializing in the production and supply of medical devices, instruments and equipment for a wider range of medical fields, including ENT. It sells nasal inserts, Rhino Rocket 30-second nasal tampons and others.

• Innovia Medical, founded in 1978, is a company specializing in surgery in various fields, such as aesthetics, ear, nose and throat. The company offers AbsorbENT Anatomical Nasal Packs for the treatment of nosebleeds. It uses three-dimensional interconnected open cells that are soft and malleable.

• Nipro, founded in 1954, is a Japanese medical device company. The company’s ExadoseTNasal Spray has an innovative two-step quantitative delivery method. The unique plunger design ensures that half of the dose is delivered precisely to each nasal cavity.

Key Market Events

• In July 2023, the Food and Drug Administration (FDA) approved the over-the-counter RiViveT nasal spray developed by Harm Reduction Therapeutics for the acute treatment of opioid overdose.

• In November 2022, Aptar Pharma, a leading player in drug delivery and active material science solutions, unveiled a partnership with TFF Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing and distributing innovative drug products using its proprietary Thin Film Freezing technology platform. The collaboration focuses on developing and evaluating dry powder vaccine delivery using TFF Pharmaceutical’s Thin Film Freezing technology in conjunction with Aptar Pharma’s exclusive Unidose (UDS) nasal powder delivery system.

• In December 2020, Medtronic introduced Novapak Nasal Sinus Packing and Stent, a disposable, dissolvable package designed specifically for use after sinus surgery. It helps control bleeding, prevents adhesions, and creates a moist healing environment, allowing for a rapid patient recovery.

Market segmentation

By product

• Injectable

• Gel

• Spray

• Sauces

By type

• Bio-resorbable

• Non-absorbable

By the end user

By geography

• North America

• South America

• Europe

• Middle East and Africa

• Asia and Pacific

Featured companies

• Meril’s Life

• Anthony’s Products

• Medtronic

• Entsho

• Innovia Medical

• Cenefom

• Nipro

• Lohmann & Rauscher

• Medline

Key Features

For more information on this report, please visit https://www.researchandmarkets.com/r/gqhrky

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. We provide the latest data on international and regional markets, key industries, leading companies, new products and the latest trends.

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900